Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line

Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line

Submitted by admin on October 31, 2019 - 11:57pm
Source: 
Motley Fool
News Tags: 
Bristol-Myers Squibb
earnings
Headline: 
Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line
snippet: 

BMS had more positive news when it announced third-quarter results before the market opened on Thursday. Here are the highlights from the company's Q3 update.

Do Not Allow Advertisers to Use My Personal information